Circulating cell-free DNA content as blood based biomarker in endometrial cancer
Oncotarget2017Vol. 8(70), pp. 115230–115243
Citations Over TimeTop 11% of 2017 papers
Lucia Cicchillitti, Giacomo Corrado, Martina De Angeli, Emanuela Mancini, Ermelinda Baiocco, Lodovico Patrizi, Ashanti Zampa, Roberta Merola, Aline Martayan, Laura Conti, Giulia Piaggio, Enrico Vizza
Abstract
Our data indicate that assessment of total and mitochondrial cfDNA levels in blood sera and the relative NLR and MLR in blood obtained from preoperative patients may help clinical management and prognosis in EC.
Related Papers
- → Diabetes as a risk factor for death following endometrial cancer(2004)85 cited
- → Endometrial cancer and obesity(2019)39 cited
- → Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid(2005)13 cited
- → Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma(2015)5 cited
- → Weight changes after the diagnosis of endometrial cancer(2017)